Have a feature idea you'd love to see implemented?
Let us know!
ZOM Zomedica Corp
Price (delayed)
$0.1312
Market cap
$128.57M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.07
Enterprise value
$120.9M
Based in Ann Arbor, Michigan, Zomedica is a veterinary health company creating products for dogs and cats by focusing on the unmet needs of clinical veterinarians. Zomedica's product portfolio will
Highlights
Zomedica's gross profit has increased by 13% YoY and by 3.9% from the previous quarter
The revenue is up by 11% year-on-year and by 2.5% since the previous quarter
The debt has increased by 19% YoY but it has decreased by 9% from the previous quarter
Zomedica's quick ratio has decreased by 39% YoY and by 6% QoQ
The equity fell by 22% YoY and by 2.8% QoQ
Key stats
What are the main financial stats of ZOM
Market
Valuations
Earnings
Shares outstanding
979.95M
Market cap
$128.57M
Enterprise value
$120.9M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.63
Price to sales (P/S)
4.81
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.52
Revenue
$26.73M
EBIT
-$61.39M
EBITDA
-$59.99M
Free cash flow
-$30.79M
Per share
Balance sheet
Liquidity
EPS
-$0.07
Free cash flow per share
-$0.03
Book value per share
$0.21
Revenue per share
$0.03
TBVPS
$0.12
Total assets
$214.12M
Total liabilities
$11.27M
Debt
$2.08M
Equity
$202.84M
Working capital
$79.21M
Debt to equity
0.01
Current ratio
10.82
Quick ratio
9.83
Net debt/EBITDA
0.13
Margins
Efficiency
Dividend
EBITDA margin
-224.5%
Gross margin
69.6%
Net margin
-230.1%
Operating margin
-247.4%
Return on assets
-26.4%
Return on equity
-27.8%
Return on invested capital
-56.2%
Return on capital employed
-29.8%
Return on sales
-229.7%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ZOM stock price
How has the Zomedica stock price performed over time
Intraday
0%
1 week
-4.93%
1 month
5.47%
1 year
-24.47%
YTD
-34.47%
QTD
-4.37%
Financial performance
How have Zomedica's revenue and profit performed over time
Revenue
$26.73M
Gross profit
$18.61M
Operating income
-$66.13M
Net income
-$61.51M
Gross margin
69.6%
Net margin
-230.1%
The operating income has plunged by 161% YoY and by 2.5% from the previous quarter
Zomedica's operating margin has plunged by 135% YoY
Zomedica's gross profit has increased by 13% YoY and by 3.9% from the previous quarter
ZOM's net income is down by 11% since the previous quarter
Growth
What is Zomedica's growth rate over time
Valuation
What is Zomedica stock price valuation
P/E
N/A
P/B
0.63
P/S
4.81
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.52
The company's EPS fell by 17% QoQ
ZOM's P/B is 77% below its 5-year quarterly average of 2.7 and 10% below its last 4 quarters average of 0.7
The equity fell by 22% YoY and by 2.8% QoQ
The P/S is 20% below the last 4 quarters average of 6.0
The revenue is up by 11% year-on-year and by 2.5% since the previous quarter
Efficiency
How efficient is Zomedica business performance
Zomedica's ROA has decreased by 18% from the previous quarter
ZOM's return on equity is down by 18% since the previous quarter
The ROIC has contracted by 11% from the previous quarter
The company's return on sales fell by 4.8% QoQ
Dividends
What is ZOM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ZOM.
Financial health
How did Zomedica financials performed over time
Zomedica's quick ratio has decreased by 39% YoY and by 6% QoQ
ZOM's current ratio is down by 37% year-on-year and by 5% since the previous quarter
The debt is 99% less than the equity
The equity fell by 22% YoY and by 2.8% QoQ
The debt has increased by 19% YoY but it has decreased by 9% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.